Clinical Trial Update: "Cancersensor": Circadian Rhythms

View source ↗

Summary

A completed clinical trial update for the Cancersensor study examining circadian rhythm monitoring in metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Metastatic Colorectal Cancer | Status: COMPLETED